Form D · Other

Bedrocan Cannabis Corp.

Toronto, A6 · CIK 0001621524

Offering snapshot reported Oct 7, 2014 · SEC filing

Reported sold: $0
Investors reported: 1
Minimum accepted: $0
First sale: Aug 20, 2014

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 7, 2014	Initial	$0	No comparison	1	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired, Other
Exemptions: 06b
Duration over one year: No
Business combination: Yes

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-225925

Per escrow rls conditions of Bedrocan Canada Inc offering 5/2014 each sub rcpt automatically exchgd for 1 com sh & 1/2 com sh purch wrnt. The cmn shs & cmn sh purch wrnts then exchgd 1:1 w/Bedrocan Cannabis Corp for no consideration due to an amalgamation

Source: Form D, filed Oct 7, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Roderick Budd	Director
Tjalling Erkelens	Executive
Barry Fishman	Director
Murray Goldman	Director
Alan Mandelzys	Director
Michael Singer	Executive
H. Hamish Sutherland	Executive
Marc Wayne	Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:

250 A Eglinton Avenue East
Toronto, A6, M4P 3E7